Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls

Addiction Biology

Volumn 16, Issue 3, 2011, Pages 467-484

  Tremblay, Anne Marie ^a   Desmond, Renée C ^a   Poulos, Constantine X ^a   Zack, Martin ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

D2; Dopamine; Expectancy; Gambling; Instrumental; Slot machine

Indexed keywords

DOPAMINE; HALOPERIDOL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; MACHINE; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RECEPTOR BLOCKING; REWARD; SIGNAL TRANSDUCTION;

ADULT; ANTIPSYCHOTIC AGENTS; CONDITIONING, OPERANT; FEMALE; GAMBLING; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; MOTIVATION; RECEPTORS, DOPAMINE D2; REINFORCEMENT SCHEDULE; REWARD; STATISTICS AS TOPIC;

EID: 79959838845     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2010.00208.x     Document Type: Article

References (71)

1. Ahn S, Phillips AG (1999) Dopaminergic correlates of sensory-specific satiety in the medial prefrontal cortex and nucleus accumbens of the rat. J Neurosci 19:RC29.
2. Bakken IJ, Gotestam KG, Grawe RW, Wenzel HG, Oren A (2009) Gambling behavior and gambling problems in Norway 2007. Scand J Psychol 50:333-339.
3. Barry DT, Steinberg MA, Wu R, Potenza MN (2008) Characteristics of black and white callers to a gambling helpline. Psychiatr Serv 59:1347-1350.
4. Berridge KC (2007) The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 191:391-431.
5. Bjork JM, Momenan R, Smith AR, Hommer DW(2008) Reduced posterior mesofrontal cortex activation by risky rewards in substance-dependent patients. Drug Alcohol Depend 95:115-128.
6. Bland JM, Altman DG (1996) Transforming data. BMJ 312:770. (Pubitemid 26091245)
7. Bostwick JM, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE (2009) Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc 84:310-316.
8. Bryk AS, Raudenbush SW (1992) Hierarchical Linear Models: Applications and Data Analysis Methods. Newbury Park, CA: Sage.
9. Dalley JW, Everitt BJ (2009) Dopamine receptors in the learning, memory and drug reward circuitry. Semin Cell Dev Biol 20:403-410.
10. Dranias MR, Grossberg S, Bullock D (2008) Dopaminergic and non-dopaminergic value systems in conditioning and outcome-specific revaluation. Brain Res 1238:239-287.
11. Evans MG (1991) The problem of analyzing multiplicative composites: interactions revisited. Am Psychol 46:6-15.
12. Fields HL, Hjelmstad GO, Margolis EB, Nicola SM (2007) Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci 30:289-316. (Pubitemid 47218759)
13. Fiorillo CD, Tobler PN, Schultz W (2003) Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299:1898-1902. (Pubitemid 36356659)
14. Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L (2008) A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav 89:298-303.
15. Frank MJ, O'Reilly RC (2006) A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 120:497-517. (Pubitemid 44050530)
16. Goldstein RZ, Alia-Klein N, Tomasi D, Zhang L, Cottone LA, Maloney T, Telang F, Caparelli EC, Chang L, Ernst T, Samaras D, Squires NK, Volkow ND (2007) Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry 164:43-51.
17. Goldstein RZ, Tomasi D, Alia-Klein N, Honorio Carrillo J, Maloney T, Woicik PA, Wang R, Telang F, Volkow ND (2009) Dopaminergic response to drug words in cocaine addiction. J Neurosci 29:6001-6006.
18. Grace AA (2000) The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. Addiction 95 (Suppl 2):S119-S128.
19. Grant JE, Brewer JA, Potenza MN (2006) The neurobiology of substance and behavioral addictions. CNS Spectr 11:924-930. (Pubitemid 46025638)
20. Grant JE, Kim SW, Hollander E, Potenza MN (2008) Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl) 200:521-527.
21. Haertzen CA (1965) Addiction Research Center Inventory (ARCI): development of a general drug estimation scale. JNerv Ment Dis 141:300-307.
22. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
23. Johnson AW, Gallagher M, Holland PC (2009) The basolateral amygdala is critical to the expression of pavlovian and instrumental outcome-specific reinforcer devaluation effects. J Neurosci 29:696-704.
24. Kassinove JI, Schare ML (2001) Effects of the "near miss" and the "big win" on persistence at slot machine gambling. Psychol Addict Behav 15:155-158.
25. Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC, Shaffer HJ (2008) DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 38:1351-1360.
26. Korotkova TM, Klyuch BP, Ponomarenko AA, Lin JS, Haas HL, Sergeeva OA (2007) Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors. Neuropharmacology 52:626-633. (Pubitemid 46137978)
27. Leiserson V, Pihl RO (2007) Reward-sensitivity, inhibition of reward-seeking, and dorsolateral prefrontal working memory function in problem gamblers not in treatment. J Gambl Stud 23:435-455.
28. Lesieur HR, Blume SB (1987) The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144:1184-1188. (Pubitemid 17147523)
29. Lex A, Hauber W (2008) Dopamine D1 and D2 receptors in the nucleus accumbens core and shell mediate Pavlovian-instrumental transfer. Learn Mem 15:483-491. (Pubitemid 352008670)
30. Loba P, Stewart SH, Klein RM, Blackburn JR (2001) Manipulations of the features of standard video lottery terminal (VLT) games: effects in pathological and non-pathological gamblers. J Gambl Stud 17:297-320. (Pubitemid 33643784)
31. McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE, Jr (2008) Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry 69:433-440.
32. Mehta MA, Sahakian BJ, McKenna PJ, Robbins TW (1999) Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology (Berl) 146:162-174. (Pubitemid 29474208)
33. Mutschler J, Bühler M, Diehl A, Mann K, Kiefer F (2010) Disulfiram, an old drug with new potential in the treatment of pathological gambling? Med Hypotheses 74:209-210.
34. Niv Y, Daw ND, Joel D, Dayan P (2007) Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl) 191:507-520. (Pubitemid 46355878)
35. Nordstrom AL, Farde L, Halldin C (1992) Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology (Berl) 106:433-438.
36. Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E (2006) Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. CNS Spectr 11:956-964. (Pubitemid 46025641)
37. Pehek EA (1999) Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. J Pharmacol Exp Ther 289:14-23.
38. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442:1042-1045. (Pubitemid 44330261)
39. Petry NM(2003) A comparison of treatment-seeking pathological gamblers based on preferred gambling activity. Addiction 98:645-655.
40. Phillips AG, Vacca G, Ahn S (2008) A top-down perspective on dopamine, motivation and memory. Pharmacol Biochem Behav 90:236-249. (Pubitemid 351790712)
41. Pizzagalli DA, Evins AE, Schetter EC, Frank MJ, Pajtas PE, Santesso DL, Culhane M (2008) Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology (Berl) 196:221-232.
42. Potenza MN (2008) Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci 363:3181-3189.
43. Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, O'Malley SS (2001) Gender-related differences in the characteristics of problem gamblers using a gambling helpline. Am J Psychiatry 158:1500-1505. (Pubitemid 32847252)
44. Quickfall J, Suchowersky O (2007) Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord 13:535-536. (Pubitemid 350110554)
45. Redish AD, Jensen S, Johnson A, Kurth-Nelson Z (2007) Reconciling reinforcement learning models with behavioral extinction and renewal: implications for addiction, relapse, and problem gambling. Psychol Rev 114:784-805.
46. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C (2005) Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8:147-148. (Pubitemid 40194043)
47. Riba J, Kramer UM, Heldmann M, Richter S, Munte TF (2008) Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS ONE 3:e2479.
48. Robbins TW, Everitt BJ (1999) Drug addiction: bad habits add up. Nature 398:567-570. (Pubitemid 29183674)
49. Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 (Suppl 2):S91-S117. (Pubitemid 30650375)
50. Saez-Abad C, Bertolin-Guillen JM (2008) Personality traits and disorders in pathological gamblers versus normal controls. J Addict Dis 27:33-40.
51. Sanger DJ, Perrault G (1995) Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats. J Pharmacol Exp Ther 272:708-713.
52. Santesso DL, Evins AE, Frank MJ, Schetter EC, Bogdan R, Pizzagalli DA (2009) Single dose of a dopamine agonist impairs reinforcement learning in humans: evidence from eventrelated potentials and computational modeling of striatal-cortical function. Hum Brain Mapp 30:1963-1976.
53. Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, Duzel E, Bauer A (2008) Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 28:14311-14319.
54. Shacham S (1983) A shortened version of the Profile of Mood States. J Pers Assess 47:305-306.
55. Skinner BF, ed. (1953) Science and Human Behavior. NewYork: Free Press.
56. Smith RJ (1993) Logarithmic transformation bias in allometry. Am J Phys Anthropol 90:215-228.
57. Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP (2009) Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 132:1376-1385.
58. Thanos PK, Volkow ND, Freimuth P, Umegaki H, Ikari H, Roth G, Ingram DK, Hitzemann R (2001) Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 78:1094-1103. (Pubitemid 32823158)
59. Thanos PK, Michaelides M, Umegaki H, Volkow ND (2008) D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse 62:481-486. (Pubitemid 351794174)
60. Volkow ND, Fowler JS, Wang GJ, Goldstein RZ (2002) Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol LearnMem 78:610-624. (Pubitemid 36268682)
61. Volkow ND, Wang GJ, Fowler JS, Molina PE, Logan J, Gatley SJ, Gifford A, Ding YS, Wong C, Pappas NR, Zhu W, Swanson JM (2003) Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl) 166:264-270. (Pubitemid 36384773)
62. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575-1579. (Pubitemid 350106758)
63. Voon V, Potenza MN, Thomsen T (2007a) Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol 20:484-492. (Pubitemid 47051998)
64. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007b) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212-216.
65. Waelti P, Dickinson A, Schultz W (2001) Dopamine responses comply with basic assumptions of formal learning theory. Nature 412:43-48. (Pubitemid 32851502)
66. Weiner I, Joel D (2002) Dopamine in schizophrenia: dysfunctional information processing in basal gangliathalamocortical split circuits. In: Dopamine in the CNS II (Handbook of Experimental Pharmacology). Di Chiara G (ed). Springer-Verlag: Berlin. pp. 417-472.
67. Wheeler BW, Rigby JE, Huriwai T (2006) Pokies and poverty: problem gambling risk factor geography in New Zealand. Health Place 12:86-96. (Pubitemid 41501780)
68. Williams RJ, West BL, Simpson RI (2007) Prevention of Problem Gambling: A Comprehensive Review of the Evidence. Guelph: Ontario Problem Gambling Research Centre.
69. Wrase J, Schlagenhauf F, Kienast T, Wustenberg T, Bermpohl F, Kahnt T, Beck A, Strohle A, Juckel G, Knutson B, Heinz A (2007) Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage 35:787-794. (Pubitemid 46402977)
70. Zack M, Poulos CX (2007) A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology 32:1678-1686. (Pubitemid 47076378)
71. Zack M, Poulos CX (2009) Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. J Psychopharmacol 23:660-671.